Best AI Index Fund to Buy
Over the last two years, companies with a focus on…
Buy
52
ANF Quote, Financials, Valuation and Earnings
Last price:
$78.42
Seasonality move
:
2.89%
Day range:
$78.36 - $83.02
52-week range:
$65.40 - $194.38
Dividend yield:
0%
P/E ratio:
7.73x
P/S ratio:
0.82x
P/B ratio:
3.14x
Volume:
5.1M
Avg. volume:
2.9M
1-year change:
-56.02%
Market cap:
$3.7B
Revenue:
$4.9B
EPS (TTM):
$10.16
Analysts' Opinion
-
Consensus RatingAbercrombie & Fitch has received a consensus rating of Hold. The company's average rating is a Hold based on 4 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $119.80, Abercrombie & Fitch has an estimated upside of 52.63% from its current price of $78.49.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $82.00 representing 100% downside risk from its current price of $78.49.
Fair Value
-
According to the consensus of 9 analysts, Abercrombie & Fitch has 52.63% upside to fair value with a price target of $119.80 per share.
ANF vs. S&P 500
-
Over the past 5 trading days, Abercrombie & Fitch has overperformed the S&P 500 by 0.37% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Abercrombie & Fitch does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Abercrombie & Fitch has grown year-over-year revenues for 10 quarters straight. In the most recent quarter Abercrombie & Fitch reported revenues of $1.1B.
Earnings Growth
-
Abercrombie & Fitch earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Abercrombie & Fitch reported earnings per share of $1.59.
Enterprise value:
3.1B
EV / Invested capital:
--
Price / LTM sales:
0.82x
EV / EBIT:
4.20x
EV / Revenue:
0.63x
PEG ratio (5yr expected):
0.29x
EV / Free cash flow:
7.55x
Price / Operating cash flow:
9.86x
Enterprise value / EBITDA:
3.64x
Gross Profit (TTM):
$3.2B
Return On Assets:
16.98%
Net Income Margin (TTM):
10.6%
Return On Equity:
43.48%
Return On Invested Capital:
42.02%
Operating Margin:
9.25%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-04-30 | 2024-04-30 | 2025-04-30 | 2024-04-30 | 2025-04-30 | |
| Income Statement | ||||||
| Revenue | $3.7B | $4.5B | $5B | $1B | $1.1B | |
| Gross Profit | $2.2B | $2.9B | $3.2B | $677.5M | $680.2M | |
| Operating Income | $133M | $580.5M | $712.5M | $129.8M | $101.5M | |
| EBITDA | $278.9M | $760M | $865.2M | $178.3M | $109M | |
| Diluted EPS | $0.70 | $8.04 | $10.16 | $2.14 | $1.59 | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.5B | $1.2B | $1.1B | $1.5B | $1.4B | |
| Total Assets | $3.1B | $2.6B | $2.6B | $3B | $3.1B | |
| Current Liabilities | $817M | $853M | $769.5M | $919.7M | $998.9M | |
| Total Liabilities | $2.1B | $1.9B | $1.8B | $1.9B | $1.9B | |
| Total Equity | $950M | $704.8M | $711M | $1.1B | $1.2B | |
| Total Debt | $344.3M | $303.9M | $297.2M | $213.1M | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-04-30 | 2024-04-30 | 2025-04-30 | 2024-04-30 | 2025-04-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $214.9M | $749M | $611.4M | $95M | -$4M | |
| Cash From Investing | -$168.5M | -$149.7M | -$289.6M | -$38.9M | -$30.8M | |
| Cash From Financing | -$60.3M | -$182.2M | -$676.4M | -$93M | -$234.5M | |
| Free Cash Flow | $30.2M | $598.7M | $416.6M | $56.1M | -$54.8M | |
ANF
Sector
Market Cap
$3.7B
$410.3M
Price % of 52-Week High
40.38%
71.02%
Dividend Yield
0%
0%
Shareholder Yield
15.07%
3.91%
1-Year Price Total Return
-56.02%
-13.51%
Beta (5-Year)
1.468
0.782
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$78.29
200-day SMA
Sell
Level
$120.13
Bollinger Bands (100)
Sell
Level
69.1 - 119.06
Chaikin Money Flow
Buy
Level
116M
20-day SMA
Buy
Level
$76.45
Relative Strength Index (RSI14)
Buy
Level
51.75
ADX Line
Buy
Level
22.24
Williams %R
Buy
Level
-81.6389
50-day SMA
Buy
Level
$75.05
MACD (12, 26)
Buy
Level
1.48
25-day Aroon Oscillator
Buy
Level
76
On Balance Volume
Neutral
Level
291.6M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.687)
Buy
CA Score
(Annual)
Level (0.7161)
Buy
Beneish M-Score
(Annual)
Level (-3.2021)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-0.976)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Abercrombie & Fitch Co is a specialty retailer that sells casual clothing, personal-care products, and accessories for men, women, and children. It sells direct to consumers through its stores and websites, which include the Abercrombie & Fitch, Abercrombie kids, and Hollister brands. Most stores are in the United States, but the company does have many stores in Canada, Europe, and Asia. All stores are leased. Abercrombie ships to well over 100 countries via its websites. The company sources its merchandise from dozens of vendors that are primarily located in Asia and Central America. Abercrombie has two distribution centers in Ohio to support its North American operations. It uses third-party distributors for sales in Europe and Asia.
Stock Forecast FAQ
In the current month, ANF has received 4 Buy ratings 5 Hold ratings, and 0 Sell ratings. The ANF average analyst price target in the past 3 months is $119.80.
-
Where Will Abercrombie & Fitch Stock Be In 1 Year?
According to analysts, the consensus estimate is that Abercrombie & Fitch share price will rise to $119.80 per share over the next 12 months.
-
What Do Analysts Say About Abercrombie & Fitch?
Analysts are divided on their view about Abercrombie & Fitch share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Abercrombie & Fitch is a Sell and believe this share price will drop from its current level to $82.00.
-
What Is Abercrombie & Fitch's Price Target?
The price target for Abercrombie & Fitch over the next 1-year time period is forecast to be $119.80 according to 9 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is ANF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Abercrombie & Fitch is a Hold. 5 of 9 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of ANF?
You can purchase shares of Abercrombie & Fitch via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Abercrombie & Fitch shares.
-
What Is The Abercrombie & Fitch Share Price Today?
Abercrombie & Fitch was last trading at $78.42 per share. This represents the most recent stock quote for Abercrombie & Fitch. Yesterday, Abercrombie & Fitch closed at $78.49 per share.
-
How To Buy Abercrombie & Fitch Stock Online?
In order to purchase Abercrombie & Fitch stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
